Lotte Chilsung Beverage Co Ltd (005305)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 63,500.00 |
|---|---|
| 52-week range | 62,400.00 – 93,400.00 |
| Return, 1 month / 3 months | −2.6% / −7.0% |
| Return, 1 year / 3 years | −3.0% / +9.6% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -29.0% |
| Average daily value traded | 57.52M KRW |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lotte Chilsung Beverage is a South Korean drinks maker based in Seoul. It produces a wide range of beverages, including carbonated soft drinks, fruit juices, bottled water, coffee drinks and sports drinks, sold under brands familiar to Korean consumers. The company also makes alcoholic beverages such as beer and soju. Its products reach households, retailers, restaurants and other outlets across Korea, and it is part of the wider Lotte group of companies.
The shares are listed on the Korea Stock Exchange in Korea under the code 005305, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lotte Chilsung Beverage Co Ltd (005305) trades on the Korea Stock Exchange in Korea. It last closed at KRW 63,500.00 on 23 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 370 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.0% and over the last three months it fell 7.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -13.5% | ||
| From 52-week high | -31.7% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.0% | ||
| 6-month return | -22.6% | ||
| 12-month return, skipping the last month | -0.4% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.0% | ||
| Liquidity | 13 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 57.52M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | −2.6% |
| 3 months | −7.0% |
| 6 months | −22.6% |
| 1 year | −3.0% |
| 3 years | +9.6% |
| 5 years | +7.6% |
Signals
| 50-day / 200-day average | 66,226.00 / 73,390.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,245.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 3,405.0000 |
| 28 Mar 2025 | KRW 3,405.0000 |
| 27 Dec 2023 | KRW 3,405.0000 |
| 28 Dec 2022 | KRW 3,305.0000 |
| 29 Dec 2021 | KRW 3,005.0000 |
| 29 Dec 2020 | KRW 2,705.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.